Literature DB >> 17485967

Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain.

Vivencio Barrios1, Carlos Escobar, Alberto Calderón, José L Llisterri, Rocio Echarri, Eduardo Alegría, Javier Muñiz, Arantxa Matalí.   

Abstract

Although blood pressure (BP) control is crucial in hypertensive patients, clinical practice guidelines agree that the goal of treatment should be aimed at not only decreasing BP but reducing global cardiovascular risk. The aim of this cross-sectional study was to evaluate BP, low-density lipoprotein cholesterol (LDL-C), and composite control rates in a hypertensive population in a primary care setting in Spain. Good BP control was defined as <140/90 mm Hg (<130/80 mm Hg for diabetics).LDL-C control rate was established according to the third report of the National Cholesterol Education Program Adult Treatment Panel criteria. A total of 12,954 patients (49.9% women, aged 62.1+/-10.7 years) were included. BP was controlled in 24.8% of patients, LDL-C in 26% of patients and, when combined, in only 8.6%. The rates of control were significantly worse in high-risk subgroups, such as high-coronary-risk, diabetic, or metabolic syndrome patients. The BP and LDL-C control rates in the hypertensive population attended to daily in primary care settings in Spain are low.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485967      PMCID: PMC8109970          DOI: 10.1111/j.1524-6175.2007.06481.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Therapeutic goal attainment in patients with hypertension and dyslipidemia.

Authors:  Michael L Johnson; Kenneth Pietz; David S Battleman; Rebecca J Beyth
Journal:  Med Care       Date:  2006-01       Impact factor: 2.983

3.  [Risk factor prevalence and drug treatment in coronary patients at hospital discharge. Results of a national multicenter registry (3C Program)].

Authors:  J A de Velasco; E Llargués; R Fitó; J Sala; A del Río; E de Los Arcos; A Llamas
Journal:  Rev Esp Cardiol       Date:  2001-02       Impact factor: 4.753

4.  [Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population].

Authors:  Alejandro de la Sierra; Ramón Romero; Josep Bonet; Montserrat Pérez; Juan S López; Ramón Ravella; María T Aguilera
Journal:  Med Clin (Barc)       Date:  2006-03-25       Impact factor: 1.725

5.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Authors:  T A Pearson; I Laurora; H Chu; S Kafonek
Journal:  Arch Intern Med       Date:  2000-02-28

6.  [Control of blood pressure in diabetic patients in primary care setting. DIAPA study].

Authors:  Olga García Vallejo; José Vicente Lozano; Onofre Vegazo; F Javier Jiménez Jiménez; José Luis Llisterri Caro; Josep Redón
Journal:  Med Clin (Barc)       Date:  2003-04-19       Impact factor: 1.725

7.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

8.  [Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study].

Authors:  José L Llisterri Caro; Gustavo C Rodríguez Roca; Francisco J Alonso Moreno; Salvador Lou Arnal; Juan A Divisón Garrote; José A Santos Rodríguez; Anna Raber Béjar; Rous de Castellar Sansó; Luis M Ruilope Urioste; José R Banegas Banegas
Journal:  Med Clin (Barc)       Date:  2004-02-14       Impact factor: 1.725

9.  [New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study].

Authors:  José A De Velasco; Juan Cosín; José Luis López-Sendón; Eduardo De Teresa; Manuel De Oya; Guillermo Sellers
Journal:  Rev Esp Cardiol       Date:  2002-08       Impact factor: 4.753

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  9 in total

1.  Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Authors:  Vivencio Barrios; Peter Brommer; Uwe Haag; Alberto Calderón; Carlos Escobar
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

2.  The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011.

Authors:  Giselle Sarganas; Hannelore K Neuhauser
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

3.  Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study.

Authors:  Beatriz De Rivas; Vivencio Barrios; Josep Redón; Alberto Calderón
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

4.  Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility.

Authors:  Vivencio Barrios; Carlos Escobar
Journal:  Integr Blood Press Control       Date:  2010-05-10

5.  Emerging drug combinations to optimize renovascular protection and blood pressure goals.

Authors:  Carlos Escobar; Rocio Echarri; Vivencio Barrios
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-04-03

6.  Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.

Authors:  Vivencio Barrios; Carlos Escobar; Alberto Calderon; Michael Böhm
Journal:  Vasc Health Risk Manag       Date:  2009-09-07

7.  Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.

Authors:  Konstantinos Tziomalos; Vasilios Giampatzis; Maria Baltatzi; Elias Efthymiou; Konstantia Psianou; Natalia Papastergiou; Dimitra Magkou; Vagia Bougatsa; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-13       Impact factor: 3.738

8.  Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice.

Authors:  Maja S Paulsen; Morten Andersen; Janus L Thomsen; Henrik Schroll; Pia V Larsen; Jesper Lykkegaard; Ib A Jacobsen; Mogens L Larsen; Bo Christensen; Jens Sondergaard
Journal:  J Am Heart Assoc       Date:  2012-12-31       Impact factor: 5.501

Review 9.  Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.

Authors:  Vivencio Barrios; Carlos Escobar; Rocio Echarri
Journal:  Vasc Health Risk Manag       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.